Weight gain and weight loss are not as simple as "calories in, calories out," given that countless factors affect body weight. Now, researchers from Japan have identified a gene that may serve as a master regulator of fat ...
Nov 27, 2023
0
58
Corlee Morris has dieted throughout her adult life. After her weight began climbing in high school, she spent years losing 50 or 100 pounds then gaining it back. Morris, 78, was at her heaviest in her mid-40s, standing 5 ...
Nov 27, 2023
0
2
The causes behind weight gain and obesity are complex, but many Canadians still hold negative attitudes and beliefs towards individuals who live with overweight and obesity.
Nov 22, 2023
0
0
For most of her life, Claudia Stearns dreaded Thanksgiving. As a person who struggled with obesity since childhood, Stearns hated the annual turmoil of obsessing about what she ate—and the guilt of overindulging on a holiday ...
Nov 20, 2023
0
12
In individuals with schizophrenia, accelerated continuous theta burst stimulation (cTBS) seems promising for treating obesity, according to a study published online Oct. 31 in Schizophrenia Bulletin.
Nov 18, 2023
0
10
Retatrutide, an experimental weight-loss drug that could compete against blockbusters Wegovy and Zepbound, may work wonders for obese folks with liver disease, new research shows.
Nov 15, 2023
0
1
The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorized by the UK's medicines regulation authority for use in weight loss and weight management. The decision was made on ...
Nov 15, 2023
0
0
In a finding that could change the landscape of heart disease care, the wildly popular weight-loss drug Wegovy has proved its mettle in protecting the heart after lowering the risk of cardiac problems in patients by 20%.
Nov 13, 2023
0
0
Novo Nordisk A/S unveiled details from a closely watched study that support use of Wegovy, its blockbuster weight-loss drug, to cut heart attacks and strokes in obesity patients with a history of cardiovascular disease.
Nov 13, 2023
0
0
Findings from a multi-center, international clinical trial reported by a Cleveland Clinic physician show that semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular ...
Nov 13, 2023
0
99
